28/09/2020 9:55 am Welcome to isteroids.com - BLOG

Saturday 10, Mar 2012

  Speculation on Alleged Suspension of Saunders

Posted By
Pin it Share on Tumblr

TE Weslye Saunders will face suspension for the first four game of the 2012 season, according to reports.

However, there was no verification of whether the suspension was for the substance abuse policy (drugs, narcotics, etc.) or the anabolic steroid and related substances policy (HGH, anabolic steroids, etc.) of the NFL.

It has been believed that the claimed positive test of Saunders came not from PEDs or medication, but rather, because of a therapeutic pharmaceutical that included an ingredient on the league’s record of suspended ingredients.

Tuesday 14, Jun 2011

  Ban on Kolo Toure highlights confusing drug punishment procedures

Posted By
Pin it Share on Tumblr

Ban on Kolo Toure highlights confusing drug punishment proceduresThe Manchester City doctor, Jamie Butler, alleged to have authorized Kolo Toure taking diet pills, has been cleared of all blame related to the failed drugs test of the Ivory Coast defender last March.

Toure originally claimed that that doctor sanctioned the supplements he borrowed from his wife in an attempt to lose weight.

From Footballfancast.com:

Unfortunately, the former captain at Eastlands was absent for the team’s first cup triumph in 35 years when his brother, Yaya, converted the only goal in City’s 1-0 win against Stoke in last month’s FA Cup Final. “Before I signed for City I told Kolo I wanted to come to England to play with him and win something together,” said Yaya before the Wembley showpiece. “That won’t happen on Saturday, and that means it will be a hard moment for him, and for me as well.”

The public response to Toure’s misdemeanor was initially empathetic, but a deeper inspection of the player’s intent suggests that he was looking to gain an advantage over his Premiership compatriots by attempting to lose weight in a purportedly unnatural fashion. The extent of his punishment is arguably proportionate to the committed crime, but taking a glance at recent cases of substance abuse in football illustrates a confusing and unpredictable process for punishing those guilty of failing drugs tests.

Toure will have to wait until September 2nd until he can feature again for City having been banned for a total of six months by the Football Association.

Friday 06, May 2011

  Boxer cleared after positive test

Posted By
Pin it Share on Tumblr

Boxer cleared after positive testA boxer from Ireland, whose identity has been witheld by the Association under anti-doping rules drawn up last year, has been found not guilty of substance abuse by the IABA despite testing positive for an anabolic steroid during the National Championships.

The fighter is the first Irish amateur boxer to deliver a positive sample in either domestic or international competition.

The boxer involved tested positive for the anabolic steroid stanozol.

Sunday 30, Jan 2011

  More Australian kids abusing steroids

Posted By
Pin it Share on Tumblr

More Australian kids abusing steroidsA major survey conducted in secondary schools has found 2.4 per cent of 12 to 17 year olds reported using the muscle enhancing injections. After the survey results were disclosed, Australian schools have been told to broaden their drug education programs.

This was a much higher usage rate than that seen across the population, according to Dr Matthew Dunn, a researcher at the National Drug and Alcohol Research Centre (NDARC).

Dr Dunn said school sport and athletics programs should also highlight the risks involved in steroid abuse.

Monday 13, Sep 2010

  Erik Ainge enters rehabilitation facility

Posted By
Pin it Share on Tumblr

Erik Ainge enters rehabilitation facilityErik Ainge, the New York Jets backup quarterback, recently entered a drug treatment, rehabilitation facility for “recreational issues.”

It was disclosed by a team source to the Daily News that the Jets are extremely disappointed in what looks to be a relapse for the quarterback and do not have a timetable for Ainge’s return.

With uncertainty around the return of Ainge, fellow quarterback Kellen Clemens and Kevin O’Connell will be battling out for the final quarterback spot.

Tuesday 27, Jul 2010

  Crohn’s disease patients likely to benefit from Naltrexone

Posted By
Pin it Share on Tumblr

Crohn's disease patients likely to benefit from NaltrexoneNaltrexone, which is an FDA-approved drug, is presently prescribed by physicians for easing out withdrawal symptoms linked with substance abuse. The drug could also be used for providing relief to patients afflicted with Crohn’s disease.

This finding was presented by Jill P. Smith, a gastroenterology specialist and researcher at the College of Medicine and Penn State Milton S. Hershey Medical Center in Los Angeles at the National Association of Gastroenterologists annual Digestive Diseases Week conference.

The finding was revealed by a pilot study by the Penn State College of Medicine.

Friday 09, Jul 2010

  Naltrexone effective in providing relief to patients with Crohn’s disease

Posted By
Pin it Share on Tumblr

Naltrexone effective in providing relief to patients with Crohn’s diseaseNaltrexone, the FDA-approved drug presently used for providing relief in terms of withdrawal symptoms from substance abuse, could be used as an effective treatment option for patients afflicted with Crohn’s disease.

According to a Pilot study by Penn State College of Medicine, the drug is currently used to ease down symptoms of drug and alcohol abuse and could be more than useful for patients with Crohn’s disease.

Findings of the study were presented by Jill P. Smith, a gastroenterology specialist and researcher at the College of Medicine and Penn State Milton S. Hershey Medical Center in Los Angeles at the National Association of Gastroenterologists annual Digestive Diseases Week conference.

Friday 16, Apr 2010

  Naltrexone effective for offering relief to patients with Crohn’s disease

Posted By
Pin it Share on Tumblr

Naltrexone effective for offering relief to patients with Crohn's diseaseAn FDA-approved drug for easing withdrawal symptoms from substance abuse, Naltrexone, may prove its worth to bring relief to patients suffering from Crohn’s disease as well.

According to a Penn State College of Medicine pilot study, the drug that is currently used to ease symptoms of drug and alcohol addiction can bring significant relief to Crohn’s patients.

These findings were presented by Jill P. Smith, a gastroenterology specialist and researcher at the College of Medicine and Penn State Milton S. Hershey Medical Center in Los Angeles at the National Association of Gastroenterologists annual Digestive Diseases Week conference.

Tuesday 09, Mar 2010

  Crohn’s sufferers on the verge of expecting relief

Posted By
Pin it Share on Tumblr

Crohn's sufferers on the verge of expecting reliefAn FDA-approved drug, naltrexone, presently recommended and used for easing symptoms of withdrawal from substance abuse could be an effective option for providing relief to people with Crohn’s disease.

This finding was disclosed by a pilot study by Penn State College of Medicine.

Crohn’s disease is believed to affect nearly 500,000 people in the United States alone.

Jill P. Smith, a gastroenterology specialist and researcher at the College of Medicine and Penn State Milton S. Hershey Medical Center, presented her findings in Los Angeles at the National Association of Gastroenterologists annual Digestive Diseases Week conference.

Friday 12, Feb 2010

  Naltrexone useful for patients suffering with Crohn’s disease

Posted By
Pin it Share on Tumblr

Naltrexone useful for patients suffering with Crohn's diseaseAn FDA-approved drug to ease out withdrawal symptoms associated with substance abuse has the ability to prove its additional worth by proving effective for offering significant relief to patients suffering from Crohn’s disease.

Naltrexone, the drug, is currently recommended for easing drug abuse and addiction symptoms, and can be effective for treating patients with Crohn’s disease, as per a Penn State College of Medicine pilot study.

Jill P. Smith, a gastroenterology specialist and researcher at the College of Medicine and Penn State Milton S. Hershey Medical Center in Los Angeles at the National Association of Gastroenterologists annual Digestive Diseases Week conference, presented this finding.

Next »